Induction of labour versus expectant management for nulliparous women over 35 years of age: a multi-centre prospective, randomised controlled trial

BMC Pregnancy and Childbirth

Jim Thornton³  Gordon Smith¹  Chris Wildsmith⁴  Carol McCormick²  Marion Macpherson²  George Bugg²  Kate F Walker² 

[1] University of Cambridge, Cambridge, UK;Nottingham University Hospitals NHS Trust, Nottingham, UK;University of Nottingham, Nottingham, UK;Trustee for SANDS, London, UK

关键词: Caesarean delivery;    Perinatal outcome;    Advanced maternal age;    Induction of labour;   

Others  :  1151537
DOI  :  10.1186/1471-2393-12-145

 received in 2012-11-12, accepted in 2012-11-29,  发布年份 2012

【 摘 要 】

Background

British women are increasingly delaying childbirth. The proportion giving birth over the age of 35 rose from 12% in 1996 to 20% in 2006. Women over this age are at a higher risk of perinatal death, and antepartum stillbirth accounts for 61% of all such deaths. Women over 40 years old have a similar stillbirth risk at 39 weeks as women who are between 25 and 29 years old have at 41 weeks.

Many obstetricians respond to this by suggesting labour induction at term to forestall some of the risk. In a national survey of obstetricians 37% already induce women aged 40–44 years. A substantial minority of parents support such a policy, but others do not on the grounds that it might increase the risk of Caesarean section. However trials of induction in other high-risk scenarios have not shown any increase in Caesarean sections, rather the reverse. If induction for women over 35 did not increase Caesareans, or even reduced them, it would plausibly improve perinatal outcome and be an acceptable intervention. We therefore plan to perform a trial to test the effect of such an induction policy on Caesarean section rates.

This trial is funded by the NHS Research for Patient Benefit (RfPB) Programme.

Design

The 35/39 trial is a multi-centre, prospective, randomised controlled trial. It is being run in twenty UK centres and we aim to recruit 630 nulliparous women (315 per group) aged over 35 years of age, over two years. Women will be randomly allocated to one of two groups:

Induction of labour between 39^0/7 and 39^6/7 weeks gestation.

Expectant management i.e. awaiting spontaneous onset of labour unless a situation develops necessitating either induction of labour or Caesarean Section.

The primary purpose of this trial is to establish what effect a policy of induction of labour at 39 weeks for nulliparous women of advanced maternal age has on the rate of Caesarean section deliveries. The secondary aim is to act as a pilot study for a trial to answer the question, does induction of labour in this group of women improve perinatal outcomes? Randomisation will occur at 36^0/7 – 39^6/7 weeks gestation via a computerised randomisation programme at the Clinical Trials Unit, University of Nottingham. There will be no blinding to treatment allocation.

Discussion

The 35/39 trial is powered to detect an effect of induction of labour on the risk of caesarean section, it is underpowered to determine whether it improves perinatal outcome. The current study will also act as a pilot for a larger study to address this question.

Trial registration

ISRCTN11517275

【 授权许可】

   
2012 Walker et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Lewis G (Ed): The confidential enquiry into maternal and child health (CEMACH). saving Mothers’ lives: reviewing maternal deaths to make motherhood safer – 2003–2005. The seventh report on confidential enquiries into maternal deaths in the united kingdom. London: CEMACH; 2007.
• [2]Smith GCS, Cordeaux Y, White IR, Pasupathy D, Missfelder-Lobos H, Pell JP, Charnock-Jones DS, Fleming M: The effect of delaying childbirth on primary cesarean section rates. PloS Med 2008, 5(7):e144.
• [3]Confidential enquiry into maternal and child health (CEMACH) perinatal mortality 2006: England, Wales and northern Ireland. London: CEMACH; 2008.
• [4]Joseph KS, Allen AC, Dodds L, Turner LA, Scott H, Liston R: The perinatal effects of delayed childbearing. Obstet Gynecol 2005, 105:6.
• [5]Jacobsson B, Ladfors L, Milsom I: Advance maternal Age and adverse perinatal outcome. Obstet Gynecol 2004, 104:4.
• [6]Smith GCS: Life-table analysis of the risk of perinatal death at term and post term in singleton pregnancies. Am J Obstet Gynecol 2001, 184:489-496.
• [7]Reddy UM, Ko CW, Willinger M: Maternal age and the risk of stillbirth throughout pregnancy in the united states. Am J Obstet Gynecol 2006, 195:764-770.
• [8]Audit Commission: First class delivery: Improving maternity services in England and Wales. London: Audit Commission; 1997.
• [9]Nicholson JM, Parry S, Caughey AB, Rosen S, Keen A, Macones GA: The impact of the active management of risk in pregnancy at term on birth outcomes: a randomized clinical trial. Am J Obstet Gynecol 2008, 198:511. e1-511.e15
• [10]Walker KF, Bugg GJ, Macpherson M, Thornton J: Induction of labour at term for women over 35 years old: a survey of the view of women and obstetricians. Eur J Obstet Gynecol Reprod Biol 2012.
• [11]Hannah ME, Ohlsson A, Farine D, Hewson SA, Hodnett RN, Myher TL, Wang EEL, Weston JA, Willan AR: Induction of labour compared with expectant management for prelabor rupture of the membranes at term. N Eng J Med 1996, 334:1005-1010.
• [12]Gulmezoglu AM, Crowther CA, Middleton P: Induction of labour for improving birth outcomes for women at or beyond term (review). The Cochrane Library 2007, (4):Art. No.: CD004945.
• [13]Koopmans CM, Bijlenga D, Groen H, et al.: The HYPITAT study group. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multi-centre, open-label randomised controlled trial. Lancet 2009, 374:979-988.
• [14]Boers KE, Vijgen SM, Bijlenga D, et al.: DIGITAT study group. Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT). BMJ 2010, 341:c7087.
• [15]Dencker A, et al.: Childbirth experience questionnaire (CEQ): development and evaluation of a multidimensional instrument. BMC Pregnancy Childbirth 2010, 10:81. BioMed Central Full Text